Intarcia Therapeutics
Latest round
- Series E
Last raised
- Sep 2016
Total raised
- $817M
Investors
- 50
About Intarcia Therapeutics
Founded in 1997 and headquartered in Boston, US, Intarcia Therapeutics, Inc. specializes in drug delivery systems. The company has undergone significant developments in its business strategy to enhance its therapeutic offerings. Kurt Graves serves as the CEO.Intarcia Therapeutics, Inc. is known for its advanced drug delivery systems designed to improve the treatment of chronic diseases.Intarcia generates revenue through the sale of its proprietary drug delivery systems and related services., a portfolio company of Sanofi Ventures and JDRF T1D Fund. This acquisition is expected to support the integration of Intarcia's innovative drug delivery systems into broader therapeutic strategies. Future plans include expanding the reach of its products into new markets and enhancing its pipeline with additional therapies designed for chronic conditions.
Who invested in Intarcia Therapeutics
50 investors across 11 rounds
See all investors in Intarcia Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series E
Sep 2, 2016
Amount
$184M
Investors
Series D
Mar 27, 2014
Amount
$200M
Investors
Series C
Nov 29, 2012
Amount
$156M
Investors
Series C
Jan 1, 2012
Amount
$84M
Investors
Series B
Apr 28, 2008
Amount
$25M
Investors
Series B
Mar 29, 2007
Amount
$23M
Investors
Series E
Dec 1, 2004
Amount
$50M
Investors
Series D
Jun 30, 2003
Amount
$43M
Investors
Series C
Aug 31, 2000
Amount
$38M
Investors
Series B
Apr 27, 1999
Amount
$12M
Investors
Series A
Aug 14, 1997
Amount
$2M
Investors
Questions about Intarcia Therapeutics
Who invested in Intarcia Therapeutics?
Intarcia Therapeutics has 50 investors on record across 11 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Intarcia Therapeutics raised?
Intarcia Therapeutics has raised 11 venture rounds. Sign up free to see how much each round raised and the total.
When did Intarcia Therapeutics last raise money?
Intarcia Therapeutics's most recent round on record is a Series E, in Sep 2016.
What does Intarcia Therapeutics do?
Founded in 1997 and headquartered in Boston, US, Intarcia Therapeutics, Inc.
Where is Intarcia Therapeutics headquartered?
Intarcia Therapeutics is headquartered in Boston, US.
Which VCs invest in companies like Intarcia Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Intarcia Therapeutics's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series E
Raising like Intarcia Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.